NasdaqCM - Delayed Quote USD
Dyadic International, Inc. (DYAI)
0.9700
-0.0350
(-3.48%)
At close: June 4 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 600k | 1.5M | 4.2M | 5.5M |
| Low Estimate | 600k | 1.5M | 4.2M | 5.5M |
| High Estimate | 600k | 1.5M | 4.2M | 5.5M |
| Year Ago Sales | 385.9k | 1.96M | 3.5M | 4.2M |
| Sales Growth (year/est) | 55.48% | -23.37% | 20.16% | 30.95% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.06 | -0.07 | -0.04 | -- |
| EPS Actual | -0.07 | -0.01 | -0.05 | -0.07 |
| Difference | -0.01 | 0.06 | -0.01 | -- |
| Surprise % | -7.69% | 85.71% | -25.00% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DYAI | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/24/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/3/2023 |
| Downgrade | Dawson James: Buy to Neutral | 7/18/2022 |
Related Tickers
ZURA Zura Bio Limited
1.1800
+9.77%
ORGS Orgenesis Inc.
1.7500
-10.21%
ALA.AX Arovella Therapeutics Limited
0.0760
-2.56%
ANEB Anebulo Pharmaceuticals, Inc.
1.0500
-2.78%
OSRH OSR Holdings, Inc.
1.3600
+4.62%
CYTOF Altamira Therapeutics Ltd.
0.0930
0.00%
BRTX BioRestorative Therapies, Inc.
1.7650
-0.90%
COYA Coya Therapeutics, Inc.
5.71
+1.06%
XTLB XTL Biopharmaceuticals Ltd.
1.2150
+1.25%
IPHA Innate Pharma S.A.
2.1400
+0.47%